GD
Grandfield & Dodd Portfolio holdings
AUM
$1.71B
This Quarter Return
+0.79%
1 Year Return
+14.85%
3 Year Return
+57.47%
5 Year Return
+112%
10 Year Return
+284.72%
AUM
$1.02B
AUM Growth
+$1.02B
(+0.46%)
Cap. Flow
+$2M
Cap. Flow
% of AUM
0.2%
Top 10 Holdings %
Top 10 Hldgs %
30.27%
Holding
183
New
2
Increased
49
Reduced
56
Closed
6
Top Buys
| 1 |
Blackbaud
BLKB
|
$893K |
| 2 |
John Wiley & Sons Class A
WLY
|
$632K |
| 3 |
US Bancorp
USB
|
$577K |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$560K |
| 5 |
Chevron
CVX
|
$434K |
Top Sells
| 1 |
Amdocs
DOX
|
$582K |
| 2 |
Stryker
SYK
|
$505K |
| 3 |
Microsoft
MSFT
|
$420K |
| 4 |
ARRY
Array Biopharma Inc
ARRY
|
$369K |
| 5 |
Goldman Sachs
GS
|
$321K |
Sector Composition
| 1 | Technology | 25.57% |
| 2 | Healthcare | 17.23% |
| 3 | Financials | 11.97% |
| 4 | Consumer Staples | 10.84% |
| 5 | Industrials | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Philip Morris
PM
$260B
| $813K | 0.08% |
10,708
+147
| +1% | +$11.2K |
|
102
Alcon
ALC
$39.5B
| $797K | 0.08% |
13,668
-5,148
| -27% | -$300K |
|
103
SPDR Gold Trust
GLD
$107B
| $795K | 0.08% |
5,727
| – | – |
|
104
Visa
V
$683B
| $786K | 0.08% |
4,570
-30
| -0.7% | -$5.16K |
|
105
Vanguard Large-Cap ETF
VV
$44.5B
| $774K | 0.08% |
5,680
| – | – |
|
106
Dentsply Sirona
XRAY
$2.85B
| $773K | 0.08% |
14,502
-2,600
| -15% | -$139K |
|
107
Bristol-Myers Squibb
BMY
$96B
| $772K | 0.08% |
15,224
-150
| -1% | -$7.61K |
|
108
DuPont de Nemours
DD
$32.2B
| $769K | 0.08% |
10,787
-87
| -0.8% | -$6.2K |
|
109
Boeing
BA
$177B
| $734K | 0.07% |
1,928
| – | – |
|
110
Incyte
INCY
$16.5B
| $723K | 0.07% |
9,740
+845
| +9% | +$62.7K |
|
111
Fiserv
FI
$75.1B
| $684K | 0.07% |
6,601
+105
| +2% | +$10.9K |
|
112
Vanguard FTSE All-World ex-US ETF
VEU
$48.6B
| $682K | 0.07% |
13,670
| – | – |
|
113
Charles Schwab
SCHW
$174B
| $673K | 0.07% |
16,092
| – | – |
|
114
Jacobs Solutions
J
$17.5B
| $666K | 0.07% |
7,277
| – | – |
|
115
NextEra Energy, Inc.
NEE
$148B
| $663K | 0.07% |
2,845
| – | – |
|
|
RDS.A
116
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $653K | 0.06% |
11,098
| – | – |
|
117
Eli Lilly
LLY
$657B
| $646K | 0.06% |
5,775
-150
| -3% | -$16.8K |
|
118
CSX Corp
CSX
$60.6B
| $630K | 0.06% |
9,100
| – | – |
|
119
McDonald's
MCD
$224B
| $620K | 0.06% |
2,887
| – | – |
|
120
Consolidated Edison
ED
$35.4B
| $581K | 0.06% |
6,146
| – | – |
|
121
BioMarin Pharmaceuticals
BMRN
$11.2B
| $570K | 0.06% |
8,463
+930
| +12% | +$62.6K |
|
122
H.B. Fuller
FUL
$3.29B
| $563K | 0.06% |
12,094
| – | – |
|
123
Amazon
AMZN
$2.44T
| $559K | 0.06% |
322
-8
| -2% | -$13.9K |
|
124
Target
TGT
$43.6B
| $558K | 0.05% |
5,219
| – | – |
|
125
Omnicom Group
OMC
$15.2B
| $557K | 0.05% |
7,111
| – | – |
|